This presentation introduces the concept of pharmacovigilance, defined by the WHO as 'the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug related problem', and summarizes the extent to which it is done in Africa (programmes tend to be more developed in North Africa), and factors that contribute to the existence of a pharmacovigilance programme in African countries. Lessons learned are listed, and recommendations are made for the improvement of pharmacovigilance in Africa.
Presentation from ‘Pharmacovigilance of new antimalarials in the field: challenges and opportunities’. Symposium from American Society of Tropical Medicine and Hygiene 58th Annual Meeting, Washington, DC, USA, 20 November 2009.
Pharmacovigilance Systems In Africa: North Africa / Sub-Saharan Africa